Supplements and Botanicals · Antioxidant Supplements
N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome
Fulghesu AM et al., 2002
12 works
Anna Maria Fulghesu
Associated Professore, Dipartimento di Chirurgia, Università degli Studi di Cagliari Facoltà di Medicina e Chirurgia
ORCID ScopusSciProfilesWeb of Science
Regularly publishes research on Opioid Peptides, Ovulatory Disturbances, and Insulin Sensitizing Agents.
Subjects
12 works
Ultrasound · Transvaginal Ultrasound
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio
Fulghesu AM et al., 2001
Neuroendocrinology · Opioid Peptides
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study
Fulghesu AM et al., 2001
Neuroendocrinology · Opioid Peptides
Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism
Villa P et al., 1999
Neuroendocrinology · Opioid Peptides
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease
Fulghesu AM et al., 1998
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Effect of opioid blockade on insulin metabolism in polycystic ovarian disease
Fulghesu AM et al., 1995
Neuroendocrinology · Opioid Peptides
Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion
Lanzone A et al., 1995
Polycystic ovary disease. A risk factor for gestational diabetes?
Lanzone A et al., 1995
Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome
Lanzone A et al., 1993
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease
Fulghesu AM et al., 1993
Neuroendocrinology · Opioid Peptides
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease
Lanzone A et al., 1991
Ovarian Hormones · Androgens
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist
Lanzone A et al., 1990
